As an innovative CRO, we specialize in delivering a unique blend of consulting services and technological solutions tailored for biopharmaceutical companies and regulatory bodies, such as the FDA.

At the heart of AvanSight’s offerings is our cutting-edge clinical trial decision-support platform. This platform empowers industry and government scientists with the tools they need to make informed decisions, both in designing clinical trials and evaluating their outcomes. With AvanSight, advancing medical innovation becomes a more efficient, clear-cut process.

Our History

Established in 2020, our journey began with a vision to redefine industry standards by delivering unparalleled service to organizations of all sizes, across various trial phases. Disenchanted with the transactional approach and the often subpar quality of existing CROs, we were driven to create a paradigm shift.

Our philosophy is centered on fostering a culture of excellence, robust partnership, and a shared commitment to clinical success. We are more than just a CRO; we are your strategic ally in the journey to bring groundbreaking pharmaceuticals to the market.

Meet our team

Our comprehensive suite of professionals caters to a diverse team, ranging from seasoned architects to renowned engineers.

Ray Zhu

Founder & CEO

Roger Zhang

CTO

Philip Chen

CCO

Lynn Lin

CFO

Let’s Chat

  • Trial design consultation.
  • Statistical data review.
  • Regulatory submission reporting and support.